Estrella Immunopharma, Inc.
ESLA · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $44 | $39 | $59 | $58 |
| - Cash | $1 | $4 | $0 | $4 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $43 | $35 | $60 | $54 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$9 | -$7 | -$1 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$7 | -$1 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.25 | -0.21 | -0.17 | -0.29 |
| % Growth | -19% | -23.5% | 41.4% | – |
| Operating Cash Flow | -$8 | -$16 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$8 | -$16 | -$1 | -$1 |